|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:496-505
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From Schneider Children's Hospital of the Long Island Jewish Medical Center,a University of Michigan Medical Center,b and the Albert Einstein College of Medicine,c New Hyde Park, NY.
Read at the Seventy-eighth Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 3-6, 1998.
Received for publication May 8, 1998. Revisions requested June 11, 1998. Revisions received Nov 12, 1998. Accepted for publication Nov 12, 1998. Address for reprints: Hani A. Hennein, MD, Section of Pediatric Cardiothoracic Surgery, Schneider Children's Hospital of the Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY 11040.
Background: Cardiopulmonary bypass is associated with the production of both proinflammatory and anti-inflammatory cytokines, the balance of which leads to varying degrees of postoperative systemic inflammation. Arteriovenous modified ultrafiltration effectively reduces total body water and improves postoperative hemodynamic and homeostatic functions. Venovenous modified ultrafiltration is a modification of this technique, which has the potentially added advantage of eliminating the obligatory left-to-right shunt associated with arteriovenous modified ultrafiltration. We tested the hypothesis that venovenous modified ultrafiltration is a safe and effective method of achieving ultrafiltration in children after cardiopulmonary bypass.
Methods: Thirty-eight pediatric patients were randomly assigned to undergo conventional, venovenous (n = 13), or no ultrafiltration venovenous (n = 13), and controls (n = 12). Perioperative, cardiopulmonary, and cytokine (tumor necrosis factor
, interleukin-1ß, interleukin-6, interleukin-8, and interleukin-10) data were collected for statistical analysis.
Results: Compared with patients in the conventional ultrafiltration and control groups, patients undergoing venovenous modified ultrafiltration had the greatest volume of ultrafiltrate removed (46.9 ± 8.4 mL/kg vs 20.1 ± 5.0 mL/kg and 0 mL/kg for conventional ultrafiltration and control groups, respectively; P = .0001), least increase in total body water (1.91% ± 1.49% vs 3.90% ± 1.86% and 8.24% ± 3.41%; P = .05), greatest rise in hematocrit (39.7% ± 1.7% vs 33.8% ± 2.1% and 29.6% ± 2.3%; P = .006), and shortest length of hospital stay (4.41 ± 0.28 days vs 6.69 ± 1.47 days and 8.38 ± 1.11 days; P = .03, P = .03).
Conclusions: Venovenous modified ultrafiltration is a safe and effective method of reducing the increase in total body water and duration of postoperative convalescence after cardiopulmonary bypass.
This article has been cited by other articles:
![]() |
K. Charette, Y. Hirata, A. Bograd, L. Mongero, J. Chen, J. Quaegebeur, and R. Mosca 180 ml and less: Cardiopulmonary bypass techniques to minimize hemodilution for neonates and small infants Perfusion, September 1, 2007; 22(5): 327 - 331. [Abstract] [PDF] |
||||
![]() |
G. D. Williams, C. Ramamoorthy, L. Chu, G. B. Hammer, K. Kamra, M. G. Boltz, K. Pentcheva, J. P. McCarthy, and V. M. Reddy Modified and conventional ultrafiltration during pediatric cardiac surgery: Clinical outcomes compared J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1291 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, A. Hoschtitzky, M. L. Allen, M. J. Elliott, and A. N. Redington An Analysis of Oxygen Consumption and Oxygen Delivery in Euthermic Infants After Cardiopulmonary Bypass With Modified Ultrafiltration Ann. Thorac. Surg., October 1, 2004; 78(4): 1389 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Chew, V. Brix-Christensen, H. B Ravn, I. Brandslund, E. Ditlevsen, J. Pedersen, K. Hjortholm, O. K Hansen, E. Tunnesen, and V. E Hjortdal Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study Perfusion, September 1, 2002; 17(5): 327 - 333. [Abstract] [PDF] |
||||
![]() |
H. A Hennein Venovenous modified ultrafiltration after cardiopulmonary bypass in children: A prospective randomized study J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 630 - 630. [Full Text] [PDF] |
||||
![]() |
J. Grunenfelder, G. Zund, A. Schoeberlein, F. E. Maly, U. Schurr, S. Guntli, K. Fischer, and M. Turina Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults Eur. J. Cardiothorac. Surg., January 1, 2000; 17(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |